ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) Cash From Financing

Annual CFF:

$264.94M+$197.51M(+292.87%)
December 31, 2024

Summary

  • As of today, ANIP annual cash from financing is $264.94 million, with the most recent change of +$197.51 million (+292.87%) on December 31, 2024.
  • During the last 3 years, ANIP annual cash from financing has risen by +$70.35 million (+36.15%).
  • ANIP annual cash from financing is now at all-time high.

Performance

ANIP Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Quarterly CFF:

$6.34M+$8.09M(+463.19%)
September 30, 2025

Summary

  • As of today, ANIP quarterly cash from financing is $6.34 million, with the most recent change of +$8.09 million (+463.19%) on September 30, 2025.
  • Over the past year, ANIP quarterly cash from financing has dropped by -$284.69 million (-97.82%).
  • ANIP quarterly cash from financing is now -97.82% below its all-time high of $291.03 million, reached on September 30, 2024.

Performance

ANIP Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM CFF:

-$10.21M-$284.69M(-103.72%)
September 30, 2025

Summary

  • As of today, ANIP TTM cash from financing is -$10.21 million, with the most recent change of -$284.69 million (-103.72%) on September 30, 2025.
  • Over the past year, ANIP TTM cash from financing has dropped by -$268.15 million (-103.96%).
  • ANIP TTM cash from financing is now -103.72% below its all-time high of $274.76 million, reached on March 31, 2025.

Performance

ANIP TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ANIP Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+292.9%-97.8%-104.0%
3Y3 Years+36.1%+796.5%-105.8%
5Y5 Years+10000.0%+366.8%-10000.0%

ANIP Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+5268.6%-97.8%+132.2%-103.7%+65.2%
5Y5-Yearat high+5268.6%-97.8%+132.2%-103.7%+65.2%
All-TimeAll-Timeat high+1052.5%-97.8%+123.9%-103.7%+65.2%

ANIP Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$6.34M(+463.2%)
-$10.21M(-103.7%)
Jun 2025
-
-$1.75M(+82.4%)
$274.47M(-0.1%)
Mar 2025
-
-$9.91M(-101.9%)
$274.76M(+3.7%)
Dec 2024
$264.94M(+292.9%)
-$4.91M(-101.7%)
$264.94M(+2.7%)
Sep 2024
-
$291.03M(>+9900.0%)
$257.93M(+979.1%)
Jun 2024
-
-$1.45M(+92.6%)
-$29.34M(-156.1%)
Mar 2024
-
-$19.73M(-65.5%)
$52.26M(-22.5%)
Dec 2023
$67.44M(+1415.6%)
-$11.92M(-417.4%)
$67.44M(-14.5%)
Sep 2023
-
$3.75M(-95.3%)
$78.85M(+6.3%)
Jun 2023
-
$80.15M(+1862.3%)
$74.18M(+1101.9%)
Mar 2023
-
-$4.55M(-795.3%)
-$7.40M(-44.4%)
Dec 2022
-$5.13M(-102.6%)
-$508.00K(+44.2%)
-$5.13M(-102.9%)
Sep 2022
-
-$911.00K(+36.6%)
$174.83M(+1.2%)
Jun 2022
-
-$1.44M(+36.7%)
$172.72M(-11.5%)
Mar 2022
-
-$2.27M(-101.3%)
$195.05M(+0.2%)
Dec 2021
$194.59M(>+9900.0%)
$179.44M(+6037.9%)
$194.59M(+1403.5%)
Sep 2021
-
-$3.02M(-114.5%)
$12.94M(-4.7%)
Jun 2021
-
$20.90M(+866.9%)
$13.59M(+175.3%)
Mar 2021
-
-$2.73M(-23.4%)
-$18.05M(-1154.7%)
Dec 2020
-$1.44M(-215.1%)
-$2.21M(+7.1%)
-$1.44M(>-9900.0%)
Sep 2020
-
-$2.38M(+77.9%)
$3000.00(-99.8%)
Jun 2020
-
-$10.74M(-177.3%)
$1.61M(-88.4%)
Mar 2020
-
$13.89M(+1913.4%)
$13.94M(+1014.8%)
Dec 2019
$1.25M(+104.5%)
-$766.00K(+0.5%)
$1.25M(+105.1%)
Sep 2019
-
-$770.00K(-148.7%)
-$24.51M(-0.8%)
Jun 2019
-
$1.58M(+31.0%)
-$24.32M(+3.5%)
Mar 2019
-
$1.21M(+104.5%)
-$25.21M(+3.9%)
Dec 2018
-$27.82M(-138.4%)
-$26.53M(-4489.4%)
-$26.24M(-155.0%)
Sep 2018
-
-$578.00K(-183.6%)
$47.71M(+10.1%)
Jun 2018
-
$691.00K(+306.5%)
$43.35M(+2.0%)
Mar 2018
-
$170.00K(-99.6%)
$42.50M(-41.3%)
Dec 2017
$72.36M(>+9900.0%)
$47.42M(+1060.0%)
$72.36M(+187.6%)
Sep 2017
-
-$4.94M(-3128.8%)
$25.16M(-19.5%)
Jun 2017
-
-$153.00K(-100.5%)
$31.24M(-1.3%)
Mar 2017
-
$30.02M(>+9900.0%)
$31.65M(+4441.7%)
Dec 2016
-$729.00K(-168.4%)
$224.00K(-80.5%)
-$729.00K(+6.4%)
Sep 2016
-
$1.15M(+347.7%)
-$779.00K(+35.7%)
Jun 2016
-
$256.00K(+110.9%)
-$1.21M(+7.3%)
Mar 2016
-
-$2.35M(-1453.4%)
-$1.31M(-222.6%)
Dec 2015
$1.07M(-99.4%)
$174.00K(-75.6%)
$1.07M(-99.1%)
Sep 2015
-
$714.00K(+346.3%)
$124.48M(+0.2%)
Jun 2015
-
$160.00K(+788.9%)
$124.22M(+0.2%)
Mar 2015
-
$18.00K(-100.0%)
$123.95M(-27.8%)
Dec 2014
$171.65M(+4753.1%)
$123.58M(>+9900.0%)
$171.65M(+251.2%)
Sep 2014
-
$458.00K(+505.3%)
$48.88M(+0.9%)
Jun 2014
-
-$113.00K(-100.2%)
$48.42M(+10.0%)
Mar 2014
-
$47.72M(+5799.9%)
$44.03M(+1293.7%)
Dec 2013
-$3.69M(-206.3%)
$808.90K(>+9900.0%)
-$3.69M(+18.1%)
Sep 2013
-
$0.00(+100.0%)
-$4.51M(-339.2%)
Jun 2013
-
-$4.50M(>-9900.0%)
-$1.03M(-129.6%)
Mar 2013
-
$0.00(+100.0%)
$3.47M(0.0%)
Dec 2012
$3.47M
-$7900.00(-100.2%)
$3.47M(+65.0%)
Sep 2012
-
$3.48M(>+9900.0%)
$2.10M(-95.2%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$700.00(>-9900.0%)
$43.78M(+0.0%)
Mar 2012
-
$0.00(+100.0%)
$43.77M(-35.3%)
Dec 2011
$67.66M(+39.6%)
-$1.38M(-103.0%)
$67.66M(-21.2%)
Sep 2011
-
$45.16M(>+9900.0%)
$85.90M(+110.8%)
Jun 2011
-
-$13.30K(-100.1%)
$40.74M(-25.8%)
Mar 2011
-
$23.89M(+41.6%)
$54.87M(+13.2%)
Dec 2010
$48.45M(+43.9%)
$16.87M(>+9900.0%)
$48.45M(-11.0%)
Sep 2010
-
-$300.00(-100.0%)
$54.43M(-16.7%)
Jun 2010
-
$14.12M(-19.2%)
$65.34M(+27.7%)
Mar 2010
-
$17.47M(-23.5%)
$51.15M(+51.9%)
Dec 2009
$33.67M(>+9900.0%)
$22.84M(+109.3%)
$33.67M(+212.6%)
Sep 2009
-
$10.91M(>+9900.0%)
$10.77M(+5205.1%)
Jun 2009
-
-$70.00K(-460.0%)
$203.00K(-33.9%)
Mar 2009
-
-$12.50K(+79.3%)
$307.00K(-3.9%)
Dec 2008
$319.40K(-98.3%)
-$60.30K(-117.4%)
$319.50K(-21.0%)
Sep 2008
-
$345.80K(+917.1%)
$404.50K(+100.8%)
Jun 2008
-
$34.00K(>+9900.0%)
$201.40K(-98.9%)
Mar 2008
-
$0.00(-100.0%)
$18.35M(-0.8%)
Dec 2007
$18.49M(+150.5%)
$24.70K(-82.7%)
$18.49M(+0.1%)
Sep 2007
-
$142.70K(-99.2%)
$18.47M(-27.5%)
Jun 2007
-
$18.18M(>+9900.0%)
$25.47M(+249.8%)
Mar 2007
-
$142.70K(>+9900.0%)
$7.28M(-1.4%)
Dec 2006
$7.38M(+3633.2%)
$0.00(-100.0%)
$7.38M(0.0%)
Sep 2006
-
$7.15M(>+9900.0%)
$7.38M(+3010.5%)
Jun 2006
-
-$6300.00(-102.6%)
$237.40K(-16.5%)
Mar 2006
-
$243.70K(>+9900.0%)
$284.30K(+43.7%)
Dec 2005
$197.80K(-98.9%)
$0.00(0.0%)
$197.80K(-53.3%)
Sep 2005
-
$0.00(-100.0%)
$423.90K(-44.7%)
Jun 2005
-
$40.60K(-74.2%)
$766.30K(-95.7%)
Mar 2005
-
$157.20K(-30.5%)
$17.85M(-4.5%)
Dec 2004
$18.68M(+91.0%)
$226.10K(-34.0%)
$18.68M(+0.5%)
Sep 2004
-
$342.40K(-98.0%)
$18.58M(-33.4%)
Jun 2004
-
$17.12M(+1626.5%)
$27.90M(+158.9%)
Mar 2004
-
$991.60K(+695.8%)
$10.77M(+10.1%)
Dec 2003
$9.78M(+123.2%)
$124.60K(-98.7%)
$9.78M(+1.8%)
Sep 2003
-
$9.66M(>+9900.0%)
$9.60M(+117.0%)
Jun 2003
-
-$2800.00(>-9900.0%)
$4.43M(+1.0%)
Mar 2003
-
$0.00(+100.0%)
$4.38M(+0.0%)
Dec 2002
$4.38M(+15.3%)
-$53.00K(-101.2%)
$4.38M(+0.9%)
Sep 2002
-
$4.48M(>+9900.0%)
$4.34M(+5343.5%)
Jun 2002
-
-$45.50K(-3691.7%)
$79.80K(-80.1%)
Mar 2002
-
-$1200.00(+98.7%)
$401.90K(-89.4%)
Dec 2001
$3.80M(+617.2%)
-$91.90K(-142.1%)
$3.80M(-2.4%)
Sep 2001
-
$218.40K(-21.0%)
$3.89M(-8.2%)
Jun 2001
-
$276.60K(-91.9%)
$4.24M(+6.6%)
Mar 2001
-
$3.40M(>+9900.0%)
$3.98M(+576.0%)
Dec 2000
$530.00K(-87.5%)
$0.00(-100.0%)
$588.10K(0.0%)
Sep 2000
-
$565.10K(+4420.8%)
$588.10K(+2457.0%)
Jun 2000
-
$12.50K(+19.0%)
$23.00K(+119.0%)
Mar 2000
-
$10.50K(>+9900.0%)
$10.50K(>+9900.0%)
Dec 1999
$4.23M(-0.8%)
-
-
Dec 1999
-
$0.00
$0.00
Dec 1998
$4.26M
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual cash from financing year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM cash from financing year-on-year change?

What is ANI Pharmaceuticals, Inc. annual cash from financing?

The current annual cash from financing of ANIP is $264.94M

What is the all-time high annual cash from financing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual cash from financing is $264.94M

What is ANI Pharmaceuticals, Inc. annual cash from financing year-on-year change?

Over the past year, ANIP annual cash from financing has changed by +$197.51M (+292.87%)

What is ANI Pharmaceuticals, Inc. quarterly cash from financing?

The current quarterly cash from financing of ANIP is $6.34M

What is the all-time high quarterly cash from financing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly cash from financing is $291.03M

What is ANI Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?

Over the past year, ANIP quarterly cash from financing has changed by -$284.69M (-97.82%)

What is ANI Pharmaceuticals, Inc. TTM cash from financing?

The current TTM cash from financing of ANIP is -$10.21M

What is the all-time high TTM cash from financing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM cash from financing is $274.76M

What is ANI Pharmaceuticals, Inc. TTM cash from financing year-on-year change?

Over the past year, ANIP TTM cash from financing has changed by -$268.15M (-103.96%)
On this page